The Valley Desk

NCT06463665 · Interventional trial

Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer

Overall registry status Recruiting

Phase 2

Conditions Advanced Non-squamous Non-small-cell Lung Cancer, Advanced Squamous Non-Small Cell Lung Carcinoma, Metastatic Non-squamous Non Small Cell Lung Cancer, Metastatic Squamous Non-Small Cell Lung Carcinoma, Non-small Cell Lung Cancer, Non-small Cell Lung Cancer Recurrent, Non-small Cell Lung Cancer Stage III, Non-small Cell Lung Cancer Stage IV

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov